Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis

Cited by (203)

Items 101–200 of 203

1. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center
   Na Li, Ming Jiang, Wanchun Wu, Huijie Zhou, Liqun Zou · 2022 · Hematology
2. L-DEP regimen is effective as an initial therapy for adult EBV-HLH
   Leilei Chen, Jingshi Wang, Zhao Wang · 2022 · Annals of Hematology
3. Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide
   Adan A. Rios, Putao Cen, Brian Dinh, Steven R. Mays, Anisha B. Patel · 2018 · European Journal of Cancer
4. Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report
   Pierre Péterlin, Alice Garnier, Amandine Le Bourgeois, Maxime Jullien, Amélie Seguin, Marion Eveillard, Marie C. Béné, Thierry Guillaume, Patrice Chevallier · 2022 · Acta Haematologica
5. High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic Lymphohistiocytosis
   Swati Tiwari, Adrianne E. Hontz, Catherine E. Terrell, Paritha I. Arumugam, Marlene Carmo, Kimberly Risma, Michael B. Jordan, Punam Malik · 2016 · Human Gene Therapy
6. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
   Courtney M. Campbell, Avirup Guha, Tamanna Zohra Haque, Tomas G. Neilan, Daniel Addison · 2020 · Journal of Clinical Medicine
7. Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis
   Ellen Brisse, Maya Imbrechts, Tania Mitera, Jessica Vandenhaute, Carine Helena Wouters, Robert Snoeck, Graciela Andreï, Patrick Matthys · 2017 · Virology Journal
8. Clinical features, diagnosis and therapy of familial haemophagocytic lymphohistiocytosis
   Gritta Janka, Maurizio Aricò · 2021 · Acta Paediatrica
9. A brief overview of SARS-CoV-2 infection and its management strategies: a recent update
   Alakesh Das, Surajit Pathak, Madhavi Premkumar, Chitra Veena Sarpparajan, E Balaji, Asim K. Duttaroy, Antara Banerjee · 2023 · Molecular and Cellular Biochemistry
10. Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS
    Xiang Liu, Xueling Zhu, Xiaotang Zhou, Yirui Xie, Dairong Xiang, Zhikai Wan, Ying Huang, Biao Zhu · 2022 · Frontiers in Immunology
11. Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis
    Sabrin Albeituni, Ninad Oak, Heather S. Tillman, Alexa N. Stroh, Camille Keenan, Mackenzie Bloom, Kim E. Nichols · 2023 · Frontiers in Immunology
12. Assessing the effectiveness of etoposide treatment in adult haemophagocytic lymphohistiocytosis: a systematic review and meta-analysis
    Tiankuo Gao, Dina Suolitiken, Chun Yang, Chaofan Wu, Lingbo He, Yini Wang · 2025 · Clinical and Experimental Medicine
13. Modern representations of the new coronavirus and the disease caused by SARS-COV-2
    М. П. Костинов, Anna Dmitrievna Shmitko, В. Б. Полищук, Ekaterina Alexandrovna Khromova · 2020 · Infectious diseases News Opinions Training
14. Chimeric antigen receptor T cell therapy and nephrotoxicity: From diagnosis to treatment strategies
    Hua Zhou, Min Yang, Li Cui, Jingting Jiang · 2020 · International Immunopharmacology
15. Calcium-Modulating Cyclophilin Ligand Is Essential for the Survival of Activated T Cells and for Adaptive Immunity
    Siaw-Li Chan, Lonn D. Lindquist, Michael J. Hansen, Megan A. Girtman, Larry R. Pease, Richard J. Bram · 2015 · The Journal of Immunology
16. Prevalence and mortality of haemophagocytic lymphohistiocytosis in dengue fever: a systematic review and meta-analysis
    Leong Tung Ong, Roovam Balasubramaniam · 2024 · Transactions of the Royal Society of Tropical Medicine and Hygiene
17. Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies
    Jingming Wang, Huiwen Jiang, Yinqiang Zhang, Yu Hu, Heng Mei · 2024 · Expert Review of Clinical Immunology
18. Hemophagocytic lymphohistiocytosis in patients with metastatic malignant melanoma
    Sarah Stabler, Coralie Becquart, Florent Dumézy, Louis Terriou, Laurent Mortier · 2017 · Melanoma Research
19. Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis
    Honglan Wang, Yiwei Wang, Huiwen Liu, Xuejing Li, Chunyan Sun, Zhiqing Pang, Bo Zhang, Yu Hu · 2024 · International Journal of Pharmaceutics
20. Renal involvement as a unique manifestation of hemophagocytic syndrome
    Dario Roccatello, Savino Sciascia, Antonella Barreca, Carla Naretto, Mirella Alpa, Giacomo Quattrocchio, Massimo Radin, Roberta Fenoglio · 2022 · Frontiers in Medicine
21. Clinical characteristics and prognostic analysis of pediatric hemophagocytic lymphohistiocytosis using lasso-logistic regression
    Nandu Luo, Guangli Yang, Baoli Li, Pingping Zhang, Jinhua Ma, Yan Chen, Zuochen Du, Pei Yu Huang · 2024 · Annals of Hematology
22. Rapid onset of hemophagocytic lymphohistiocytosis in a patient with refractory chronic lymphocytic leukemia treated with ibrutinib
    Austin Poole, Nicole Girard, Frederic C. Clayton, Srinivas Kiran Tantravahi · 2016 · Leukemia & lymphoma/Leukemia and lymphoma
23. Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders
    Pascal Migaud, Markus Matthias Müller, Keikawus Arastéh, Marcus Hentrich, Hartmut Stocker · 2022 · Annals of Hematology
24. Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic Lymphohistiocytosis
    Sébastien Fauteux‐Daniel, Sébastien Viel, Laurie Besson, Jiang Zhang, Marie Marotel, Anne‐Laure Mathieu, Rémi Pescarmona, Emily Charrier, Thomas Henry, Alexandre Bélot et al. · 2018 · The Journal of Immunology
25. PD-1 Blockade-Induced Hemophagocytic Lymphohistiocytosis, a Dilemma Therapeutic Outcome in 2 Patients with CAEBV: A Case Series
    Leilei Chen, Jingshi Wang, Zhao Wang · 2024 · Infection and Drug Resistance
26. HLH or sepsis: the truth is in the T cells
    Melissa Hines, Kim E. Nichols · 2021 · Blood
27. Etoposide Therapy of Cytokine Storm Syndromes
    Jan‐Inge Henter, Tatiana von Bahr Greenwood · 2024 · Advances in experimental medicine and biology
28. A Novel Corona Virus (COVID-19) Pandemic, Pathogenesis, Clinical Features and Management Options, Public Health Measures
    Mukoro Duke George · 2020 · International Journal of TROPICAL DISEASE & Health
29. Bojungikgi-tang improves skin barrier function and immune response in atopic dermatitis mice fed a low aryl hydrocarbon receptor ligand diet
    You Mee Ahn, Sarah Shin, Jihye Jang, Jeeyoun Jung · 2023 · Chinese Medicine
30. Pulmonary Lymphomatoid Granulomatosis With Hemophagocytic Lymphohistiocytosis as the Initial Manifestation
    Li Xu, Xuan Zhang, Yingjuan June Lu, Yanhua Zheng, Guangxun Gao · 2020 · Frontiers in Oncology
31. Macrophage activation syndrome, a rare complication of primary Sjögren’s syndrome: a case report
    Baïdy Sy Kane, Moustapha Niasse, A. Faye, ND Diack, Boundia Djiba, M. Thierno Dieng, M. Sow, Awa Cheikh Ndao, N.S. Diagne, S. Ndongo et al. · 2019 · Journal of Medical Case Reports
32. Acute circulatory failure in critically ill patients with hemophagocytic syndrome
    Thomas Frapard, Michaël Darmon, Jehane Fadllalah, Éric Mariotte, Sandrine Valade · 2022 · Journal of Critical Care
33. Hemophagocytic Lymphohistiocytosis: Management and Special Consideration in Human Immunodeficiency Virus Positive Patients with Immune Reconstitution Syndrome
    Bikramjit S Bindra, Katherine Garcia de de Jesus, Oscar Cisneros, Vinicius Machado Jorge, Harpreet Kaur · 2019 · Cureus
34. Rapidly Fatal Hemophagocytic Lymphohistiocytosis Developing Within Six Days Following Deceased-Donor Renal Transplantation: Case Report
    Edward John Filippone, Pooja Singh, Adam Mathias Frank, Abha A. Gupta, J L Farber · 2016 · Transplantation Proceedings
35. Successful management of infection and macrophage activation syndrome patient using low-dose etoposide: A case report
    Shu-Pei Gao, Xiaofang Luo, Mohammadreza Kosari, Wenjuan Li, Yang Liu, Wei Tu, Jixin Zhong · 2024 · World Journal of Radiology
36. Hemophagocytic lymphohistiocytosis caused by multiple infections during primary chemotherapy for pediatric acute lymphoblastic leukemia: a case report
    Yaning Ao, Yusheng Huang, Xiaobo Zhou, Jiawen Li, Qing Zhang, Sujun Wu, Ying Long Fu, Jinfeng Zhang · 2024 · Frontiers in Immunology
37. Visceral leishmaniasis with hemophagocytic lymphohistiocytosis in an immunocompetent adult
    Irène Machelart, J Lapoirie, J-F Viallard, M. Mirabel, Estibaliz Lazaro, Carine Greib, E. Rivière · 2019 · Médecine et Maladies Infectieuses
38. Haemophagocytic lymphohistiocytosis in pregnancy
    Harold Wilson-Morkeh, Charlotte Frise, Taryn Youngstein · 2021 · Obstetric Medicine
39. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus
    Takahiro Ueda, Toshikazu Itabashi, Shingo Yamanishi, Yujiro Tanabe, Makoto Migita, Yasuhiko Itoh · 2020 · Journal of Nippon Medical School
40. Diagnostic dilemmas in HLH: Can T‐cell phenotyping help?
    Rebecca A. Marsh · 2017 · European Journal of Immunology
41. Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting
    Holly Wobma, Lauren A. Henderson, Christine Duncan, Susan E. Prockop, Adrienne G. Randolph, Barbara A. Degar, Leslie Lehmann, Susanne H.C. Baumeister · 2025 · Frontiers in Oncology
42. T-ing up the storm: pathogenic cycling lymphocytes in the biology of macrophage activation syndrome
    Michael T. Lam, Connie Jiang, Pui Y. Lee · 2025 · Pediatric Rheumatology
43. HLH in Adults
    Paul Graf La Rosée, Rafał Machowicz · 2017 · Springer eBooks
44. Not So BenignHemophagocytic Lymphohistiocytosis: A Rare Yet Clinically Significant Syndrome
    Miriam A. Osei, Nancy Berliner · 2024 · The Hematologist
45. Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors
    Adi Zoref‐Lorenz, Kai Lehmberg, Michael B. Jordan · 2024 · Advances in experimental medicine and biology
46. CD8+ T Cell Biology in Cytokine Storm Syndromes
    Takuya Sekine, Donatella Galgano, Giovanna Perinetti Casoni, Marie Meeths, Randy Quentin Cron, Yenan T. Bryceson · 2024 · Advances in experimental medicine and biology
47. Computational microbiome pharmacology analysis elucidates the anti-cancer potential of vaginal microbes and metabolites
    Damilola C. Lawore, Smrutiti Jena, Alicia R. Berard, Kenzie Birse, Alana Lamont, Romel D. Mackelprang, Laura Noël‐Romas, Michelle Perner, Xuanlin Hou, Elizabeth Irungu et al. · 2025 · Frontiers in Microbiology
48. Hemophagocytic Lymphohistiocytosis (HLH): A Case Series and Review
    Christine Ann Garcia, K R Haye, Theodore G. Gabig · 2016 · American Journal of Medical Case Reports
49. Development of an early mortality risk prediction model for pediatric patients with secondary hemophagocytic lymphohistiocytosis
    Nandu Luo, Guangli Yang, Pingping Zhang, Baoli Li, Yan Chen, Zuochen Du, Pei Yu Huang · 2025 · The Italian Journal of Pediatrics/Italian journal of pediatrics
50. Chimeric antigen receptor T-cell therapies related to immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: Diagnosis, high-risk factors, and management
    Yuan Clare Zhang, Jilong Yang, Huiqi Xin, Kexin Ai, Mengsu Yang, Yuhua Li, Yanjie He · 2026 · Chinese Medical Journal
51. Les lymphohistiocytoses hémophagocytaires
    G. Stalder, Camillo Ribi, Michel André Duchosal · 2018 · Praxis
52. The effectiveness of the doxorubicin-etoposide-methylprednisolone regimen for adult HLH secondary to rheumatic disease
    Dongfei Yin, Jingshi Wang, Zhao Wang · 2024 · Annals of Hematology
53. Hemophagocytic lymphohistiocytosis: do we have a solution for TMI (too much inflammation)?
    Paul Graf La Rosée, Rafał Machowicz · 2025 · Hematology
54. History of Hemophagocytic Lymphohistiocytosis
    Gritta Janka · 2019 · Springer eBooks
55. Syndrome d’activation macrophagique d’origine infectieuse : le point de vue du réanimateur
    Sandrine Valade, Emmanuel Canet, Éric Mariotte · 2018 · Médecine Intensive Réanimation
56. CD8+ T Cell Biology in Cytokine Storm Syndromes
    Takuya Sekine, Donatella Galgano, Giovanna Perinetti Casoni, Marie Meeths, Yenan T. Bryceson · 2019 · Springer eBooks
57. Acute kidney injury due to cytokine storm in patients with COVID-19 infection
    Sepehr Ebrahimi‐Dehkordi, Hasan Banitalebi, Ali Hasanpour Dehkordi · 2020 · Journal of Nephropathology
58. Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis
    Clara Vigneron, Valentine Le Stang, Justine Decroocq, Edwige Péju, Barbara Burroni, Nicolas Chapuis, Julien Charpentier, Frédéric Pène · 2022 · Acta Oncologica
59. Hemophagocytic Lymphohistiocytosis Associated with Malignancies and with Epstein-Barr Virus
    Kai Lehmberg, Fumihiro Ochi, Kim E. Nichols, Eiichi Ishii · 2017 · Springer eBooks
60. Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation
    Seidu A. Richard, Sylvanus Kampo, Marian Sackey, Maite Esquijarosa Hechavarria, Alexis D. B. Buunaaim, Eugene Dogkotenge Kuugbee, Thomas Winsum Anabah · 2020 · Current Stem Cell Research & Therapy
61. A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19
    Meredith Halpin, Adam Lerner, Manish Sagar, Praveen Govender, Bhavesh Shah, Janice Weinberg, Shayna Sarosiek, John Mark Sloan · 2023 · medRxiv
62. [Bone marrow large B-cell lymphoma manifested by hemophagocytic lymphohistiocytosis: 8 cases resport and and literature review].
    T Y Wang, Z J Li, G An, Sheng-li Deng, W W Sui, Lugui Qiu · 2018 · PubMed Central
63. Importance of immunosuppression in haemophagocytic lymphohistiocytosis caused by miliary tuberculosis
    Tine Bjørn Nielsen, Andreja Dimitrijevic, Mia Dahl Sørensen, Işık Somuncu Johansen, Dennis Lund Hansen · 2024 · BMJ Case Reports
64. Severe Dengue Associated With Hemophagocytic Lymphohistiocytosis (HLH) in an Adult ICU
    Jitendra Singh Chahar, Meru V Kumar, Afzal Azim, Banani Poddar, Mohan Gurjar, Dinesh Chandra · 2025 · Cureus
65. Severe Treatment-Refractory Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis Presenting With Neurologic Crisis in Systemic Lupus Erythematosus
    Zehra Rahman, Tiffany Scotto, Shelby Watford, Brianna Woodbeck, Kabeer Ali, Parth Desai, Maleeha Abedi, Pramod Reddy · 2026 · Cureus
66. Treatment of Newly Diagnosed HLH and Refractory Disease
    Jan‐Inge Henter, Rebecca A. Marsh, Tatiana von Bahr Greenwood · 2017 · Springer eBooks
67. Murine Models of Familial Cytokine Storm Syndromes
    Benjamin Volkmer, Peter Aichele, Jana Pachlopnik Schmid · 2019 · Springer eBooks
68. Etoposide Therapy of Cytokine Storm Syndromes
    Jan‐Inge Henter, Tatiana von Bahr Greenwood · 2019 · Springer eBooks
69. [Hemophagocytic lymphohistiocytosis: advances on etiologies, diagnosis and treatment].
    Dongjiao Wang, Hongxia Qiu · 2017 · PubMed Central
70. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases
    Francis Edem Agamah, Thomas H. A. Ederveen, Michelle Skelton, Darren Patrick Martin, Emile Rugamika Chimusa, Peter A.C. ’t Hoen · 2024 · Drug repurposing
71. Murine Models of Familial Cytokine Storm Syndromes
    Benjamin Volkmer, Tommaso Marchetti, Peter Aichele, Jana Pachlopnik Schmid · 2024 · Advances in experimental medicine and biology
72. Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors
    Kai Lehmberg · 2019 · Springer eBooks
73. Network-based multi-omics-disease-drug associations reveal drug repurposing candidates for COVID-19 disease phases
    Francis Edem Agamah, Thomas H. A. Ederveen, Michelle Skelton, Darren Patrick Martin, Emile Rugamika Chimusa, Peter A.C. 't Hoen 't Hoen · 2024
74. Przeszczepienie krwiotwórczych komórek macierzystych w nawrotowej wtórnej limfohistiocytozie hemofagocytarnej
    Bożena Katarzyna Budziszewska, Kinga Kos-Zakrzewska, Kazimierz Hałaburda, Barbara Nasiłowska, Monika Prochorec‐Sobieszek, Krzysztof Warzocha, Ewa Lech‐Marańda · 2017 · Hematologia
75. A Man With Tonsillitis and Hepatitis
    Shio Yen Tio, David K. Nickless, James McCracken, Rithin Nedumannil, Josephine M. Stewart, Craig A. Aboltins · 2018 · Clinical Infectious Diseases
76. [Research progress of lymphoma associated hemophagocytic syndrome].
    X Q Zheng, Huayuan Zhu, J Y Wang, Lei Fan, Wei Xü, Jianyong Li · 2020 · Europe PMC (PubMed Central)
77. Editorial; Haemophagocytosis Lymphohistiocytosis (HLH) in acute viral infection, increasingly recognised but not yet understood?
    Arthur Price · 2020 · Clinical Infection in Practice
78. Etoposide as an Effective Drug for Adult Macrophage Activation Syndrome: A Retrospective Study
    Lingbo He, Zhili Jin, Menghan Liu, Tingting Cui, Lin Wu, Zhao Wang, Yini Wang · 2021 · Research Square
79. Characteristics and management of patients with hemophagocytic lymphohistiocytosis masquerading as liver failure
    Yahong You, Jingshi Wang, Zhao Wang · 2021 · Research Square
80. Short-term, Low-Dose Etoposide in Refractory Adult-Onset Still’s Disease-Associated Macrophage Activation Syndrome, a Case Series Study
    Ran Wang, Ting Li, Shuang Ye, Liangjin Lv, Sheng Chen, Xiaodong Wang, Chun-de Bao, Qiong Fu · 2021 · Research Square
81. Higher efficacy of oral etoposide for mobilization of peripheral blood stem cells in patients with multiple myeloma
    Wanting Qiang, Hua Jiang, Pei Guo, Jing Lü, Jin Liu, Lu Li, Haiyan He, Xiaoxia Hu, Weijun Fu, Juan Du · 2022 · Blood Science
82. Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
    Hayley A. Gans, David B. Lewis · 2022 · Elsevier eBooks
83. Clinical features and prognostic factors of adult patients with hemophagocytic lymphohistiocytosis: a retrospective study of 130 adult patients
    Tingting Xu, Liang V. Tang, Lijuan Xiong · 2022 · Research Square
84. Síndrome hemofagocítico asociado a varicela
    César Mateo Gavidia Leiva, Ramón David Argueta Sales · 2023 · ALERTA Revista Científica del Instituto Nacional de Salud
85. Hemophagocytic Lymphohistiocytosis
    Sanjeev Kumar Sharma · 2023 · Springer eBooks
86. Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease
    Masahiro Imamura · 2023 · Cytotherapy
87. Hemophagocytic Lymphohistiocytosis
    Alisa Movsisyan, Liana Hambardzumyan, Maria Badikyan, Meri Petrosyan, Mariam Minasyan, Anna Avagyan, Julietta Simonyan, Anhelina Ivanenko, Samvel Bardakhchyan, Gevorg Tamamyan · 2023 · Elsevier eBooks
88. Comparison of different treatment regimens and analysis of prognostic factors in secondary hemophagocytic lymphohistiocytosis in adults: A single-center retrospective study
    Xing Wu, Changfeng Man, Wanying Cheng, Guangli Yin, Jiayu Huang, Jujuan Wang, Xin Gao, Tian Tian, Limin Duan, Ji Xu et al. · 2024 · Advances in Clinical and Experimental Medicine
89. EB Virus-Associated Hemophilic Syndrome: A Case Report and Literature Review
    俊娜 翁 · 2024 · Advances in Clinical Medicine
90. ADENOVIRUS TYPE 5 REACTIVATION IN T- LYMPHOBLAST HUMAN CELL AFTER ETOPOSIDE TREATMENT
    Zeenah Atwan · 2020 · Basrah Journal of veterinary Research
91. Progress in Diagnosis and Treatment of Lymphoma-Associated Hemophagocytic Syndrome
    涵越 张 · 2024 · Advances in Clinical Medicine
92. Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer
    Denis Moro‐Sibilot, Lionel Falchero, Camille Ardin, Ayoube Zouak, Olivier Molinier, Philippe Romand, Olivier Leleu, Karim Amrane, Célia Berndt, Alexandra Langlais et al. · 2024 · Respiratory Medicine and Research
93. Navigating Complexity: A Case Study on Hemophagocytic Lymphohistiocytosis Diagnosis and Management Challenges
    Julie Nguyen, Nattapron Tun, N.M.J. Burley, David Bolos · 2024 · Cureus
94. CART Cell Toxicities and Management
    Nishanth Thalambedu, Sruthi Vellanki, Anup Kumar Trikannad, Ankur Varma · 2025 · Biochemistry
95. Wolcott-Rallison syndrome – crosstalk between PERK- EIF2A and type II interferon signaling
    Megha Konduri, Devin M. Boe, Nada A. Yazigi, Khalid Khan, Brant R. Ward, Blachy J. Dávila Saldaña, Douglas R. Cavener, Bhaskar Kallakury, Alexander Kroemer, Cal Matsumoto et al. · 2025 · European Journal of Medical Genetics
96. Hemophagocytic Lymphohistiocytosis Secondary To Dengue: A Case Report
    Iarin Sebastian · 2025 · International Journal For Multidisciplinary Research
97. Epstein-Barr Virus-Associated Secondary Hemophagocytic Syndrome and Chronic Active Disease: A Literature Review
    В. Г. Потапенко, М. М. Антонов · 2025 · Clinical oncohematology
98. Macrophage Activation Syndrome-Associated Hemophagocytic Lymphohistiocytosis Triggered by Myasthenia Gravis: A Rare Hyperinflammatory Complication in a Young Adult
    Victor M. Samperio, Hiba Zahidi, Anthony Lim, Henry T. Tsai · 2026 · Journal of Investigative Medicine High Impact Case Reports
99. Étude du rôle de l’inflammasome et de la kinase Styk1 dans la régulation des lymphocytes cytotoxiques
    Sébastien Fauteux‐Daniel · 2018 · theses.fr (ABES)
100. EBV DNA load and cytokines guide risk-stratified treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis
     Longlong Xie, Xuedan Jiang, Xiao Li, Xun Li, Xiangyu Wang, Haipeng Yan, H U I Yang, Ting Luo, Zhenghui Xiao, Meiyu Yang et al. · 2026 · Virology Journal